EA200600996A1 - Композиция для полезного воздействия на кожу с использованием ключевых промежуточных продуктов клеточного метаболизма - Google Patents

Композиция для полезного воздействия на кожу с использованием ключевых промежуточных продуктов клеточного метаболизма

Info

Publication number
EA200600996A1
EA200600996A1 EA200600996A EA200600996A EA200600996A1 EA 200600996 A1 EA200600996 A1 EA 200600996A1 EA 200600996 A EA200600996 A EA 200600996A EA 200600996 A EA200600996 A EA 200600996A EA 200600996 A1 EA200600996 A1 EA 200600996A1
Authority
EA
Eurasian Patent Office
Prior art keywords
skin
composition
intermediate products
key intermediate
cellular metabolism
Prior art date
Application number
EA200600996A
Other languages
English (en)
Inventor
Джон Р. Шилтц
Original Assignee
Мэри Кей, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мэри Кей, Инк. filed Critical Мэри Кей, Инк.
Publication of EA200600996A1 publication Critical patent/EA200600996A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к новым способам и композициям, включающим ключевые компоненты метаболизма для лечения старческой, зрелой, поврежденной нарушением питания или окружающей средой кожи. Данные способы и композиции обеспечивают улучшение внешнего вида кожи, физиологических функций, клинических свойств и биофизических свойств.
EA200600996A 2003-11-18 2004-10-26 Композиция для полезного воздействия на кожу с использованием ключевых промежуточных продуктов клеточного метаболизма EA200600996A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/716,378 US20050106194A1 (en) 2003-11-18 2003-11-18 Compositions for achieving benefits in skin using key cellular metabolic intermediates
PCT/US2004/035404 WO2005051288A2 (en) 2003-11-18 2004-10-26 Compositions for achieving benefits in skin using key cellular metabolic intermediates

Publications (1)

Publication Number Publication Date
EA200600996A1 true EA200600996A1 (ru) 2007-04-27

Family

ID=34574409

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600996A EA200600996A1 (ru) 2003-11-18 2004-10-26 Композиция для полезного воздействия на кожу с использованием ключевых промежуточных продуктов клеточного метаболизма

Country Status (12)

Country Link
US (1) US20050106194A1 (ru)
EP (1) EP1684701A2 (ru)
KR (1) KR20060116213A (ru)
CN (1) CN1901875A (ru)
AR (1) AR048051A1 (ru)
AU (1) AU2004292956A1 (ru)
BR (1) BRPI0416686A (ru)
CA (1) CA2545462A1 (ru)
EA (1) EA200600996A1 (ru)
MX (1) MXPA06005564A (ru)
TW (1) TW200518781A (ru)
WO (1) WO2005051288A2 (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7956031B2 (en) 2005-05-31 2011-06-07 Naidu Lp Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
US8021659B2 (en) 2006-04-28 2011-09-20 Naidu Lp Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
DE102006047164A1 (de) * 2006-09-29 2008-04-03 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninmethylester und einem oder mehreren Hautbefeuchtungsmitteln
DE102006047166A1 (de) * 2006-09-29 2008-04-03 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninethylester und einem oder mehreren Hautbefeuchtungsmitteln
DE102007032393A1 (de) * 2007-07-10 2009-01-29 Henkel Ag & Co. Kgaa Advanced Glycation Endproducts als Wirkstoffe
FR2918878A1 (fr) * 2007-07-16 2009-01-23 Oreal Utilisation d'un facteur naturel d'hydratation a titre d'agent protecteur des levres fragiles
DE102008059703A1 (de) * 2008-12-01 2010-06-02 Henkel Ag & Co. Kgaa Neue kosmetische Zusammensetzungen mit haarwuchsinhibierender Wirkung
KR101457068B1 (ko) * 2012-09-06 2014-10-31 권선진 돼지껍데기로부터 추출된 콜라겐단백질을 이용한 천연 마사지팩 제조방법
US10413528B2 (en) 2014-10-20 2019-09-17 John H. Plumb Methods to inhibit infection during wound healing with topical compositions including amino acids
US9833393B2 (en) * 2015-09-24 2017-12-05 Elc Management Llc Method and compositions for treating skin
KR101861583B1 (ko) * 2016-07-01 2018-05-28 전남대학교산학협력단 피지 분비 촉진용 조성물
CN110785161B (zh) 2017-06-23 2023-06-20 宝洁公司 用于改善皮肤外观的组合物和方法
EP3749751A4 (en) * 2018-02-09 2022-02-23 Keio University COMPOSITIONS AND METHODS FOR INDUCING CD8+ T LYMPHOCYTES
KR20200139776A (ko) * 2018-04-04 2020-12-14 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 피부 치료용 조성물
CA3102288A1 (en) 2018-07-03 2020-01-09 The Procter & Gamble Company Method of treating a skin condition
WO2021247496A1 (en) 2020-06-01 2021-12-09 The Procter & Gamble Company Method of improving penetration of a vitamin b3 compound into skin
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
US20230329989A1 (en) * 2020-09-29 2023-10-19 Conopco, Inc., D/B/A Unilever A personal care composition comprising amino acids
US20220133705A1 (en) * 2020-11-05 2022-05-05 Physiomefit, Llc Composition for increasing skin thickness
CN114177348B (zh) * 2021-12-14 2023-02-10 华北理工大学 一种医用液体敷料及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957971A (en) * 1974-07-29 1976-05-18 Lever Brothers Company Moisturizing units and moisturizing compositions containing the same
US5037648A (en) * 1989-11-20 1991-08-06 Joiner Evelyn S Skin conditioning preparation having a pH above 7, method and method of making
FR2685201B1 (fr) * 1991-12-23 1994-03-18 Oreal Utilisation du methylsulfate de 4-[(2-oxo-3-bornylidene)methyl]-phenyltrimethylammonium dans une composition de deformation permanente des cheveux pour la protection, contre la lumiere.
US5654266A (en) * 1992-02-10 1997-08-05 Chen; Chung-Ho Composition for tissues to sustain viability and biological functions in surgery and storage
US5720963A (en) * 1994-08-26 1998-02-24 Mary Kay Inc. Barrier disruption treatments for structurally deteriorated skin
US6495126B1 (en) * 1999-07-20 2002-12-17 Mary Kay Inc. Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
US7235397B1 (en) * 2000-04-14 2007-06-26 Gensys, Inc. Methods and compositions for culturing spirochete and treating spirochetal diseases

Also Published As

Publication number Publication date
AU2004292956A1 (en) 2005-06-09
BRPI0416686A (pt) 2007-02-06
WO2005051288A3 (en) 2005-08-18
WO2005051288A2 (en) 2005-06-09
MXPA06005564A (es) 2007-01-26
EP1684701A2 (en) 2006-08-02
AR048051A1 (es) 2006-03-29
CA2545462A1 (en) 2005-06-09
CN1901875A (zh) 2007-01-24
TW200518781A (en) 2005-06-16
US20050106194A1 (en) 2005-05-19
KR20060116213A (ko) 2006-11-14

Similar Documents

Publication Publication Date Title
EA200600996A1 (ru) Композиция для полезного воздействия на кожу с использованием ключевых промежуточных продуктов клеточного метаболизма
EA200601107A1 (ru) Композиции, получаемые из морских растений, для обеспечения питания для старческой и поврежденной окружающей средой кожи
HK1085140A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
DK1660528T3 (da) Mutein af tåre-lipocalin
WO2005013892A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
CL2004000647A1 (es) Compuestos derivados de heterociclicos de sulfonamida que contienen fluoro y trifluoro alquilo; composicion farmaceutica; kit farmaceutico; procedimiento de preparacion; y su uso como inhibidores de beta amiloides para tratar alzheimer, angiopatia am
EA200601747A1 (ru) Три(цикло)замещённые амидные соединения
EA200901555A1 (ru) Композиция местного применения по уходу за кожей и способ лечения
GEP20125565B (en) Lactam compounds and their pharmaceutical use
TW200509892A (en) Novel aminobenzophenone compounds
ATE353646T1 (de) Verwendung von indol- und indolin-derivaten bei der behandlung von adipositas oder zur reduzierung der nahrungsaufnahme
NO20073574L (no) Triazolsubstituerte aminobenzofenonforbindelser
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
EA200600588A1 (ru) Соединения, содержащие галоидалкил, как ингибиторы цистеиновых протеаз
DE602005010876D1 (de) Neuartige biaromatische ppar-rezeptoren aktivierende zusammensetzungen und ihre verwendung in kosmetischen oder pharmazeutischen zusammensetzungen
MX282977B (es) Composiciones cosmeticas y metodos para usarlas para mejorar el aspecto estetico de la piel.
EP1817312A4 (en) MACROCYCLIC AMINIOPYRIDYL BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER
CY1111353T1 (el) Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης
SE0300456D0 (sv) Novel compounds
AU2002366433A1 (en) Methods and compositions for treating metabolic bone diseases relating to human endokine alpha
EP1812007A4 (en) PYRIDAZINE COMPOUNDS AND METHODS
ATE422892T1 (de) Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
EP1912963A4 (en) CYCLIC KETALS AS BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE